- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.

A new genetic test for patients with colorectal cancer, being studied at AdventHealth, can detect if a patient has cancer from a simple blood draw. The groundbreaking test could allow patients to avoid chemotherapy after having surgery to remove a tumor. The test searches for circulating tumor DNA (ctDNA), which is a sequencing technology that can detect very small amounts of tumor DNA in the body’s circulatory system.
“What we knew is that a lot of those patients were cured with surgery alone. We just didn’t have a way to know which ones had microscopic cancer left in the blood, who needed chemo and who did not,” said Dr. Mohamedtaki Tejani, medical oncologist and director of the Gastrointestinal Oncology program at the AdventHealth Cancer Institute and the AdventHealth Research Institute, told the Orlando Sentinel.
Colorectal cancer is the fourth most common cancer diagnosed in the U.S. and the second leading cause of cancer-related deaths. Dr. Tejani is leading the AdventHealth site with two National Cancer Institute clinical trials that aim to harness this sequencing technology to improve patient care. The trial related to Stage 3 colon cancer and the BESPOKE study are currently enrolling participants through a referral process with the AdventHealth Gastrointestinal Oncology Program. Click the link for each study for more information on how to enroll.
In the future, Dr. Tejani hopes this genetic test, which has to be ordered by a physician, can also be used to prescreen for very early-stage colon cancer, and also more effectively treat other cancers, such as gynecologic or pancreatic cancers.
Read the full Orlando Sentinel story here.
Recent News
AdventHealth opened the expanded Wellsville Health Park to boost rural care access, featuring more services and space for the local community.
AdventHealth Hendersonville is celebrating its Breast Center teams across Western North Carolina for earning the renewal of the prestigious national accreditation for exceptional breast cancer care.
At the annual Becker's Hospital Review conference, chief nursing officer Cathy Stankiewicz discusses how AdventHealth is strengthening its RN workforce.
The American Heart Association presents Get With The Guidelines® - Resuscitation Gold award for proven dedication to ensuring in-hospital cardiac arrest patients have access to best practices and life...
AdventHealth is opening a new Adolescent Intensive Outpatient Program (IOP) to care for teens ages 13 to 18 in our community.
A second year of student Explorers completed the program on health care careers at AdventHealth Zephyrhills by getting CPR certified.
The Emergency Nurses Association (ENA) is honoring AdventHealth Zephyrhills Emergency Department with the 2025 Lantern Award for providing exceptional patient care.
AdventHealth’s 10-year strategic plan, Vision 2030, focuses on high-quality, clinical, whole-person care and includes sweeping ecological commitments.
AdventHealth teamed up with two retired professional sports stars to help dozens of young people and their families work on their health and wellness at the first ever "Fueled for the Future" rally at...
AdventHealth Redmond is pleased to welcome Shirley Greenway, AGACNP-BC, CCRN, RNFA, to AdventHealth Medical Group Cardiology at Cedartown.
Dozens of families returned to AdventHealth Littleton for the first time since their hospital stay to reconnect with their caregivers for a morning of fun and food.
Nasia Collins, CPT, a phlebotomist at AdventHealth Gordon in Calhoun, has been honored as the latest recipient of the SonShine Award.